Cargando…

Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period

BACKGROUND: Isocitrate dehydrogenase (IDH) mutated diffuse lower-grade gliomas (dLGG) are infiltrating brain tumors and increasing evidence is in favor of early multimodal treatment. In a Scandinavian population-based setting, we wanted to study treatment patterns over the last 15 years, focusing on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Svenjeby, Caroline, Carstam, Louise, Werlenius, Katja, Bontell, Thomas Olsson, Rydén, Isabelle, Jacobsson, Julia, Dénes, Anna, Jakola, Asgeir S., Corell, Alba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758083/ https://www.ncbi.nlm.nih.gov/pubmed/36434487 http://dx.doi.org/10.1007/s11060-022-04136-y

Ejemplares similares

Seizures in patients with IDH-mutated lower grade gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2021)

The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study
por: Corell, Alba, et al.
Publicado: (2020)

Classification of Adverse Events Following Surgery in Patients With Diffuse Lower-Grade Gliomas
por: Gómez Vecchio, Tomás, et al.
Publicado: (2021)

Neurosurgical patterns of care for diffuse low-grade gliomas in Sweden between 2005 and 2015
por: Carstam, Louise, et al.
Publicado: (2019)

Longitudinal DNA methylation analysis of adult-type IDH-mutant gliomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2023)

Stemness and clinical features in relation to the subventricular zone in diffuse lower-grade glioma: an exploratory study
por: Corell, Alba, et al.
Publicado: (2022)

Preoperative Patient-Reported Outcomes in Suspected Low-Grade Glioma: Markers of Disease Severity and Correlations with Molecular Subtypes
por: Buvarp, Dongni, et al.
Publicado: (2021)

The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomas
por: Dénes, Anna, et al.
Publicado: (2023)

Socioeconomic factors affect treatment delivery for patients with low grade glioma: a Swedish population-based study
por: Carstam, Louise, et al.
Publicado: (2019)

Meningioma classification by immunohistochemistry: A replicability study
por: Näslund, Olivia, et al.
Publicado: (2022)

Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: a nationwide matched cohort study
por: Rydén, Isabelle, et al.
Publicado: (2021)

Is intracranial volume a risk factor for IDH-mutant low-grade glioma? A case–control study
por: Sagberg, Lisa Millgård, et al.
Publicado: (2022)

Correction: Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: a nationwide matched cohort study
por: Rydén, Isabelle, et al.
Publicado: (2022)

Return to work following diagnosis of low-grade glioma: A nationwide matched cohort study
por: Rydén, Isabelle, et al.
Publicado: (2020)

Spatial heterogeneity in DNA methylation and chromosomal alterations in diffuse gliomas and meningiomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2022)

Lower-Grade Gliomas: An Epidemiological Voxel-Based Analysis of Location and Proximity to Eloquent Regions
por: Gómez Vecchio, Tomás, et al.
Publicado: (2021)

Stalled oligodendrocyte differentiation in IDH-mutant gliomas
por: Wei, Yanfei, et al.
Publicado: (2023)

Moving from clinician-defined to patient-reported outcome measures for survivors of high-grade glioma
por: Rosenlund, Lena, et al.
Publicado: (2019)

How well do neurosurgeons predict survival in patients with high-grade glioma?
por: Sagberg, Lisa Millgård, et al.
Publicado: (2021)

Shared decision-making in neurosurgery: a scoping review
por: Corell, Alba, et al.
Publicado: (2021)

Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
por: Heggebø, Liv Cathrine, et al.
Publicado: (2023)

Patterns of care and clinical outcome in assumed glioblastoma without tissue diagnosis: A population-based study of 131 consecutive patients
por: Werlenius, Katja, et al.
Publicado: (2020)

Pre-operative language ability in patients with presumed low-grade glioma
por: Antonsson, Malin, et al.
Publicado: (2017)

Perioperative fatigue in patients with diffuse glioma
por: Schei, Stine, et al.
Publicado: (2020)

Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification
por: Wenger, Anna, et al.
Publicado: (2019)

Variations in the management of diffuse low-grade gliomas—A Scandinavian multicenter study
por: Munkvold, Bodil Karoline Ravn, et al.
Publicado: (2021)

Pharmacoresistant seizures and IDH mutation in low-grade gliomas
por: Correia, Carlos Eduardo, et al.
Publicado: (2021)

Indications and outcome in surgically treated asymptomatic meningiomas: a single-center case-control study
por: Näslund, Olivia, et al.
Publicado: (2020)

Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications
por: Näslund, Olivia, et al.
Publicado: (2018)

Spatial distribution of malignant transformation in patients with low-grade glioma
por: Jakola, Asgeir S., et al.
Publicado: (2020)

IDH mutation-specific radiomic signature in lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2019)

PREOPERATIVE DETERMINATION OF IDH STATUS AND GRADE IN GLIOMAS USING MRS
por: Nguyen, Thanh Binh
Publicado: (2023)

Long-term follow up of patients with WHO grade 2 oligodendroglioma
por: Carstam, Louise, et al.
Publicado: (2023)

Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial
por: Jakola, Asgeir Store, et al.
Publicado: (2018)

Low Grade Gliomas in Eloquent Locations – Implications for Surgical Strategy, Survival and Long Term Quality of Life
por: Jakola, Asgeir S., et al.
Publicado: (2012)

Vessel Size Imaging is Associated with IDH Mutation and Patient Survival in Diffuse Lower-Grade Glioma
por: Kang, Houyi, et al.
Publicado: (2020)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019)

Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial
por: Werlenius, Katja, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bjnn5a9a6e8t86ugqu2ub3ohc1